Micropharmacology of Monoclonal Antibodies in Solid Tumors: Direct Experimental Evidence for a Binding Site Barrier

Cancer Research

Volumn 52, Issue 19, 1992, Pages 5144-5153

  Sato, Jun ^b,c   van Osdol, William ^b,c   Weinstein, John N ^b,c   Perez Bacete, Miguel J ^a  

^a CLINICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG PENETRATION; GUINEA PIG; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ADENOMA, BILE DUCT; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTORADIOGRAPHY; BINDING SITES; GUINEA PIGS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; KINETICS; LYMPHOMA, B-CELL; MICE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TISSUE DISTRIBUTION;

EID: 0026739369     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gullino, P. M., and Grantham, F. H. Studies on the exchange of fluids between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice. J. Natl. Cancer Inst., 42: 771-782, 1969.
2. Kjartansson, I. An experimental study in rat with a comparison of different methods for estimation of tumor blood flow. Acta Chir. Scand. Suppl., 471: 1-74, 1976.
3. Schlom, J., Colcher, D., Hand, P. H., Wunderlich, D., Nuti, M., and Tera-moto, Y. A. Antigenic heterogeneity, modulation and evolution in breast cancer lesions as defined by monoclonal antibodies. In: M. Rich, J. C. Hager, and P. Furmanski (eds.), Understanding Breast Cancer. Clinical and Laboratory Concepts, pp. 315-358. New York: Marcel Dekker, Inc., 1983.
4. Jones, P. L., Gallagher, B. M., and Sands, H. Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts. Cancer Immunol. Immunother., 22: 139-143, 1986.
5. Blasberg, R. G., Nakagawa, H., Bourdon, M. A., Groothuis, D. R., Patlak, C. S., and Binger, D. D. Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy. Cancer Res., 47:4432-4443, 1987.
6. Sands, H., Jones, P. L., Shah, S. A., Palme, D., Vessella, R. L., and Gallagher, B. M. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. Cancer Res., 48: 188-193, 1988.
7. Jain, R. K., and Baxter, L. T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res., 48: 7022-7032, 1988.
8. Dvorak, H. F., Nagy, J. A., Dvorak, J. T., and Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133:95-109, 1988.
9. Del Vecchio, S., Reynolds, J. C., Blasberg, R. G., Neumann, R. D., Carrasquillo, J. A., Hellstrom, I., and Larson, S. M. Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography. Cancer Res., 48: 5475-5481, 1988.
10. Del Vecchio, S., Reynolds, J. C., Carrasquillo, J. A., Blasberg, R. G., Neumann, R. D., Lotze, M. T., Bryant, G. J., Farkas, R. J., and Larson, S. M. Local distribution and concentration of intravenously injected 1311-9.2.27 monoclonal antibody in human malignant melanoma. Cancer Res., 49: 2783-2789, 1989.
11. Baxter, L. T., and Jain, R. K. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res., 37: 77-104, 1989.
12. Abrams, P. G., and Oldham, R. K. Monoclonal antibody therapy of solid tumors. In: K. A. Foon and A. C. Morgan, Jr. (eds.), Monoclonal Antibody Therapy of Human Cancer, pp. 103-120. Boston: Martinus Nijhoff, 1985.
13. Meeker, T. C., Lowder, J., Maloney, D. G., Miller, R. A., Thielemans, K., Warnke, R., and Levy, R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood, 65: 1349-1363, 1985.
14. Weinstein, J. N., Eger, R. R., Covell, D. G., Black, C. D. V., Mulshine, J., Carrasquillo, J. A., Larson, S. M., and Keenan, A. M. The pharmacology of monoclonal antibodies. Ann. NY Acad. Sci., 507: 199-210, 1987.
15. Fujimori, K., Covell, D. C., Fletcher, J. E., and Weinstein, J. N. Modeling analysis of the global and microscopic distribution of IgG, F(ab')2, and Fab in tumors. Cancer Res., 49: 5656-5663, 1989.
16. Pervez, S., Epenetos, A. A., Mool, W. J., Evans, D. J., Rowlinson, G., Dhokia, B., and Krausz, T. Localization of monoclonal antibody AUAI and its F(ab2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical study. Int. J. Cancer, 3 (Suppl.); 23-29, 1988.
17. Baxter, L. T., and Jain, R. K. Transport of fluid and macromolecules in tumors II. Role of heterogeneous perfusion and lymphatics. Microvasc. Res., 40: 246-263, 1991.
18. Ong, G. L., and Mattes, M. J. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res., 49: 4264-4273, 1989.
19. Weinstein, J. N., Black, C. D. V., Barbet, J., Eger, R. R., Parker, R. J., Holton, O. D., III, Mulshine, J. L., Keenan, A. M., Larson, S. M., Carrasquillo, J. A., Sieber, S. M., and Covell, D. G. Selected issues in the pharmacology of monoclonal antibodies. In: E. Tomlinson and S. S. Davis (eds.), Site-Specific Drug Delivery, pp. 81-91. New York: John Wiley and Sons, 1986.
20. Weinstein, J. N., and van Osdol, W. The macroscopic and microscopic pharmacology of monoclonal antibodies. Int. J. Immunopharmacol., 14: 457-463, 1992.
21. Fujimori, K., Covell, D. G., Fletcher, J. E., and Weinstein, J. N. A modeling analysis of monoclonal antibody percolation through tumors: a binding site barrier. J. Nucl. Med., 31: 1191-1198, 1990.
22. Fujimori, K., Fisher, D. R., and Weinstein, J. N. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Cancer Res., 51:4821-4827, 1991.
23. van Osdol, W., Fujimori, K., and Weinstein, J. N. An analysis of monoclonal antibody distribution in microscopic tumor models: consequences of a “bind-ing-site barrier”. Cancer Res., 51:4776-4784, 1991.
24. Baxter, L. T., and Jain, R. K. Transport of fluid and macromolecules in tumors III. Role of binding and metabolism. Microvasc. Res., 41:5-23,1991.
25. Baxter, L. T., and Jain, R. K. Transport of fluid and macromolecules in tumors IV. A microscopic model of the perivascular distribution. Microvasc. Res., 41: 252-272, 1991.
26. Bernhard, M. I., Foon, K. A., Oeltmann, T. N., Key, M. E., Hwang, K. M., Gregory, C. C., Christensen, W. L., Hoyer, L. C., Hanna, M. G., Jr., and Oldham, R. K. Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chain. Cancer Res., 43: 4420-4428, 1983.
27. Rapp, H. J., Churchill, W. H., Jr., Kronman, B. S., Rolley, R. T., Hammond, W. G., and Boros, T. Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant. J. Natl. Cancer Inst., 41: 1-11, 1968.
28. Dvorak, H. F., Form, D. M., Manseaun, E., and Smith, B. D. Pathogenesis of tumor desmoplasia. 1. Immunofluorescence identification and localization of some structural proteins in line 1 and line 10 guinea pig tumors and in healing wounds. J. Natl. Cancer Inst., 73: 1195-1205, 1984.
29. Hunter, W. A., and Greenwood, F. C. Preparation of iodine-131 labeled growth hormone of high specificity. Nature (Lond.), 194:495-496, 1962.
30. Juweid, M., Sato, J., Paik, C., Onay-Basaran, S., Weinstein, J., and Neumann, R. D. A simple method for affinity purification of monoclonal antibodies (Abstract). J. Nucl. Med., 32: 1057, 1991.
31. Weinstein, J. N., Bunow, B., Weislow, O. S., Schinazi, R. F., Wahl, S. M., Wahl, L. M., and Szebeni, J. Synergistic drug combinations in AIDS therapy. Ann. NY Acad. Sci., 616: 367-384, 1990.
32. Hsu, S. M., Raine, L., and Fanger, H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
33. Foulds, L. The experimental study of tumor progression: a review. Cancer Res., 14: 327-339, 1957.
34. Hand, P. H., Nuti, N., Colcher, D., and Schlom, J. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res., 43: 728-735, 1983.
35. Rowlinson-Busza, G., Bamias, A., Krausz, T., and Epenetos, A. A. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection. Cancer Research, 51: 3251-3256, 1991.
36. Sutherland, R. Buchegger, F., Schreyer, M., Vacca, A., and Mach, J-P. Penetration and binding of radiolabeled anti-carcinoembrionic antigen monoclonal antibodies and their antigen binding fragments in human colon mul-ticellular tumor spheroids. Cancer Res., 47: 1627-1633, 1987.
37. Kwok, C. S., Cole, S. E., and Liao, S. K. Uptake kinetics of monoclonal antibody by human malignant melanoma multicell spheroids. Cancer Res., 48: 1856-1863, 1988.
38. Langmuir, V. K., Atcher, R. W., Hines, J. J., and Brechbiel, M. W. 1125-NRLU-10 kinetic studies and BISMUTH-212-NRLU-10 toxicity in LS174T multicell spheroids. J. Nucl. Med., 31: 1527-1533, 1990.
39. Langmuir, V. K., McGann, J. K., Buchegger, F., and Sutherland, R. M. The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroids. Intl. J. Rad. Appl. Instrum. BJ, 18: 753-764, 1992.
40. Shockley, R. R., Lin, K., Nagy, J. A., Tompkins, R. G., Dvorak, H. F., and Yarmush, M. L. Penetration of tumor tissue by antibodies and other immu-noproteins. Ann. NY Acad. Sci., 618:367-382, 1991.
41. Blumenthal, R. D., Fand, I., Sharkey, R. M., Boerman, O. C., Kashi, R., and Goldenberg, D. M. The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. Cancer Immunol. Immunother., 33: 351-358, 1991.
42. Hui, T. E., Fisher, D. R., Press, O. W., Eary, J. F., Weinstein, J. N., Badger, C. C., and Bernstein, I. D. Localized beta dosimetry of l31I-labeled antibodies in follicular lymphoma. Med. Phys., 19: 97-103, 1992.
43. Weinstein, J. N., and Fujimori, K. Antibody-mediated drug delivery. In: B. Hook and G. Poste (eds.), Protein Design and the Drug Development of New Therapeutics and Vaccines, pp. 359-370. New York: Plenum, 1990.